Afya Limited (AFYA)
$
17.49
-0.05 (-0.29%)
Key metrics
Financial statements
Free cash flow per share
11.5132
Market cap
8.6 Billion
Price to sales ratio
2.4940
Debt to equity
0.7432
Current ratio
1.3943
Income quality
2.1314
Average inventory
117.5 Thousand
ROE
0.1678
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Afya Limited, through its subsidiaries, operates as a prominent medical education group in Brazil, offering a diverse array of educational products and services. These include medical schools, medical residency preparatory courses, graduate courses, and various programs aimed at lifelong medical learners within its distribution network as well as to third-party medical schools. The operating expenses amount to $1,076,613,000.00 encompassing various operational costs incurred. Additionally, Afya provides digital health services through a subscription-based mobile app and website portal, which are designed to aid health professionals and students with clinical decision-making by offering tools such as medical calculators, charts, and updated content on prescriptions, clinical scores, medical procedures, and laboratory exams. The earnings per share (EPS) is reported at $6.93 indicating the company's profitability on a per-share basis. As part of its educational offerings, Afya provides health sciences courses including medicine, dentistry, nursing, and other disciplines as well as degree programs in subjects like business administration and civil engineering. The operating income ratio is 0.31 reflecting the company's operational profitability margin. As of December 31, 2021, the company operated a network of 46 undergraduate and graduate medical school campuses, consisting of 30 undergrad operating units and five approved units, with a total of 2,731 medical school seats, which included 2,481 operating seats and 278 approved seats. Founded in 1999 and headquartered in Nova Lima, Brazil, the weighted average number of diluted shares outstanding is 91,154,636.00 reflecting potential dilution effects and highlighting the company's shareholder base. The affordability of Afya’s stock at $18.04 makes it suitable for budget-conscious investors. With a market capitalization of $1,580,900,392.00 the company is classified as a small-cap player within the medical education sector. Additionally, the stock has a low average trading volume of 125,370.00 indicating lower market activity which could reflect on its liquidity. It is a key player in the Education & Training Services industry, contributing significantly to the overall market landscape, and it belongs to the Consumer Defensive sector, driving innovation and growth. The dynamic presence of Afya Limited not only enhances the educational landscape but also underscores its commitment to advancing health education in Brazil, thereby reinforcing its strategic position in the market.
Investing in Afya Limited (AFYA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Afya Limited stock to fluctuate between $14.52 (low) and $19.90 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-07-03, Afya Limited's market cap is $1,580,900,392, based on 90,388,816 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Afya Limited has a Lower Market-Cap, indicating a difference in performance.
Afya Limited pays dividends. The current dividend yield is 1.29%, with a payout of $0.23 per share.
To buy Afya Limited (AFYA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AFYA. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Revenue: $3,304,329,000 | EPS: $6.93 | Growth: 62.30%.
Visit https://www.afya.com.br/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $28.23 (2021-06-23) | All-time low: $8.73 (2022-07-12).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 9, 2025 was duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2024; (2) the re-appointment of João Paulo Seibel de Faria as an independent director of the Company with immediate effect to hold office for a two.
zacks.com
Investors with an interest in Schools stocks have likely encountered both Afya (AFYA) and K12 (LRN). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Here is how Afya (AFYA) and American Public Education (APEI) have performed compared to their sector so far this year.
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zacks.com
DPMLF, EGO, AFYA, ALSN and HMN have been added to the Zacks Rank #1 (Strong Buy) List on June 23, 2025.
businesswire.com
NOVA LIMA, Brazil--(BUSINESS WIRE)--Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A., Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing the following link https://web.lumiconnect.com/283874046 (password: afya2025), on the 24th day of June 2025 at 10:00 a.m. BRT, for the purpose of considering and, if thought fit, passi.
businesswire.com
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that its board of directors (the “Board”), following the recommendation of the Board's audit committee, recently approved the engagement of KPMG Auditores Independentes Ltda. (“KPMG”) to provide independent auditing services for the Company, replacing Ernst & Young Auditores Independentes.
seekingalpha.com
Afya Limited delivered solid Q1 results with 16% YoY revenue growth, driven by acquisitions and organic expansion, and reported strong seasonal margins. Valuation at 11–13x earnings appears fair but not compelling, given long-term risks of market saturation and increased competition in Brazil's medical education sector. Long-term concerns persist as Brazil rapidly increases its doctor supply, potentially pressuring AFYA's enrollment and pricing power in the future.
seekingalpha.com
Afya Limited (NASDAQ:AFYA ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Virgilio Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Flavio Yoshida - Bank of America Lucca Marquezini - Itau Mauricio Cepeda - Morgan Stanley Marcelo Santos - JPMorgan Unidentified Company Representative Thank you for joining us for Afya's conference call. I'm here today with Afya's CEO, Virgilio Gibbon; and our CFO, Luis Andre Blanco.
businesswire.com
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue i.
See all news